Nephrology Medical News about blood pressure

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET
Nephrology Dialysis Transplantation, 11/05/09

Philipp T et al. – SECRET provides insights into the design and conduct of studies in this area and evidence for the utility of candesartan, which showed good safety and tolerability, improved BP control and decreased proteinuria in renal transplant recipients.

<< Previous
Effects of pioglitazone on subclinical atherosclerosis and...

Next >>
Mycophenolate mofetil and intravenous cyclophosphamide are...

Beyond office sphygmomanometry: Ways to better assess blood pressure
Cleveland Clinic Journal of Medicine, 11/05/09 Relevance Score: 71%

Aliskiren Monotherapy Does Not Cause Paradoxical Blood Pressure Rises. Meta-Analysis of Data From 8 Clinical Trials
Hypertension, 11/17/09 Relevance Score: 69%

Noninvasive cardiac output and blood pressure monitoring cannot replace an invasive monitoring system in critically ill patients
BMC Anesthesiology, 10/15/09 Relevance Score: 69%

Hypertension Highlights: Updates for European Guidelines, Plus New Evidence for Blood Pressure Targets and Strategies
Internet Source, 10/14/09 Relevance Score: 69%

Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
Cochrane Reviews, 10/09/09 Relevance Score: 69%